Use of DLI to achieve complete donor chimerism in a patient receiving systemic immunosuppression for refractory AIHA post-NST
- 25 July 2005
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 36 (8) , 735-736
- https://doi.org/10.1038/sj.bmt.1705116
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Stem cell transplantation for chronic lymphocytic leukaemiaBritish Journal of Haematology, 2005
- Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantationBone Marrow Transplantation, 2004
- Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioningBlood, 2004
- Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioningBlood, 2004
- Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximabBone Marrow Transplantation, 2002
- Non-Myeloablative TransplantationHematology-American Society Hematology Education Program, 2002